Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Adenocarcinoma Of Esophagus × Itraconazole × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 1 Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy 2 tremelimumab 1 durvalumab 1 Specimen Handling 1 Risk Assessment 1 Radiofrequency Ablation 1 Observation 1 Nivolumab 1 Mass Screening 1 Itraconazole 1 Drug Therapy 1 Breath Tests 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06732388 2026-03-18

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡